Publications · 2024
Availability of Medications for Opioid Use Disorder in US Psychiatric Hospitals
JAMA Network Open , 7(11):e2444679 , 2024 · doi:10.1001/jamanetworkopen.2024.44679
Overview
This cross-sectional study examines whether US psychiatric hospitals, which frequently admit patients with co-occurring opioid use disorder, offer FDA-approved medications for that condition.
Abstract
This cross-sectional study examines the availability of medications for opioid use disorder in psychiatric hospitals in the US.
Recognition & impact
Topics
- psychiatric hospitals
- MOUD
- opioid use disorder
- behavioral health integration
- inpatient care
- co-occurring disorders
- treatment availability
How to cite
Beetham T*, Cohen SM*, Fiellin DA, Muvvala SB. Availability of Medications for Opioid Use Disorder in US Psychiatric Hospitals. JAMA Network Open, 7(11):e2444679; 2024. doi:10.1001/jamanetworkopen.2024.44679
Show BibTeX
@article{beetham2024availabilityof,
title = {{Availability of Medications for Opioid Use Disorder in US Psychiatric Hospitals}},
author = {Beetham, T. and Cohen, S. M. and Fiellin, D. A. and Muvvala, S. B.},
journal = {JAMA Network Open},
year = {2024},
volume = {7},
number = {11},
pages = {e2444679},
doi = {10.1001/jamanetworkopen.2024.44679},
url = {https://doi.org/10.1001/jamanetworkopen.2024.44679},
abstract = {This cross-sectional study examines the availability of medications for opioid use disorder in psychiatric hospitals in the US.},
keywords = {psychiatric hospitals; MOUD; opioid use disorder; behavioral health integration; inpatient care; co-occurring disorders; treatment availability},
note = {Media coverage: Clinical Advisor}
}